Press Releases Aelis Farma

Equities

AELIS

FR0014007ZB4

Real-time Euronext Paris Other stock markets 03:00:15 2024-07-05 am EDT			5-day change	1st Jan Change
12.4 ^EUR	0.00%		-3.12%	-5.34%

Apr. 18	Aelis Farma SA Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	CI
Apr. 02	Aelis Farma SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aelis Farma : Share buyback program description	Jun. 24	PU
Aelis Farma: Availability of the Description of the Share Buyback Program	Jun. 24	BU
Results of Aelis Farma Combined General Meeting of June 4, 2024	Jun. 04	BU
Aelis Farma : Availability of documents for the General meeting on June 4, 2024	May. 14	PU
Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures	May. 14	BU
Aelis Farma: Availability of the 2023 Universal Registration Document	Apr. 25	BU
Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	Apr. 18	BU
Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook	Apr. 02	BU
Aelis Farma : Inside Information / Other news releases	23-07-05	PU
Aelis Farma announces its 2023 financial calendar	23-02-01	AQ
Aelis Farma announces positive results from its safety trials in healthy volunteers and the authorization to start the first trial in people with Down syndrome with AEF0217, its drug candidate for the treatment of cognitive disorders	22-11-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer